These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prognostic relevance of the endothelial marker CD 34 in ovarian cancer. Heimburg S; Oehler MK; Papadopoulos T; Caffier H; Kristen P; Dietl J Anticancer Res; 1999; 19(4A):2527-9. PubMed ID: 10470188 [TBL] [Abstract][Full Text] [Related]
3. Mast cell density, angiogenesis, blood clotting, and prognosis in women with advanced ovarian cancer. Chan JK; Magistris A; Loizzi V; Lin F; Rutgers J; Osann K; DiSaia PJ; Samoszuk M Gynecol Oncol; 2005 Oct; 99(1):20-5. PubMed ID: 16055178 [TBL] [Abstract][Full Text] [Related]
4. Tumor angiogenesis as a prognostic factor in ovarian carcinoma: quantification of endothelial immunoreactivity by image analysis. Schoell WM; Pieber D; Reich O; Lahousen M; Janicek M; Guecer F; Winter R Cancer; 1997 Dec; 80(12):2257-62. PubMed ID: 9404702 [TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of angiogenesis in epithelial ovarian carcinoma. Alvarez AA; Krigman HR; Whitaker RS; Dodge RK; Rodriguez GC Clin Cancer Res; 1999 Mar; 5(3):587-91. PubMed ID: 10100710 [TBL] [Abstract][Full Text] [Related]
6. Intratumor microvessel density as a prognostic factor in cancer. Weidner N Am J Pathol; 1995 Jul; 147(1):9-19. PubMed ID: 7541613 [No Abstract] [Full Text] [Related]
7. The effect of cyclooxygenase-2 expression on tumor vascularity in advanced stage ovarian serous carcinoma. Ali-Fehmi R; Che M; Khalifeh I; Malone JM; Morris R; Lawrence WD; Munkarah AR Cancer; 2003 Oct; 98(7):1423-9. PubMed ID: 14508829 [TBL] [Abstract][Full Text] [Related]
8. Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Leon SP; Folkerth RD; Black PM Cancer; 1996 Jan; 77(2):362-72. PubMed ID: 8625246 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of measurements of angiogenesis in serous carcinoma of the ovary. Palmer JE; Sant Cassia LJ; Irwin CJ; Morris AG; Rollason TP Int J Gynecol Pathol; 2007 Oct; 26(4):395-403. PubMed ID: 17885489 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1. Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777 [TBL] [Abstract][Full Text] [Related]
11. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma. Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma. Kolev Y; Uetake H; Iida S; Ishikawa T; Kawano T; Sugihara K Ann Surg Oncol; 2007 Oct; 14(10):2738-47. PubMed ID: 17687613 [TBL] [Abstract][Full Text] [Related]
13. Tumor angiogenesis in gallbladder carcinoma. Sugawara Y; Makuuchi M; Harihara Y; Noie T; Inoue K; Kubota K; Takayama T Hepatogastroenterology; 1999; 46(27):1682-6. PubMed ID: 10430321 [TBL] [Abstract][Full Text] [Related]
14. Quantification of angiogenesis by the Chalkley method and its prognostic significance in epithelial ovarian cancer. Suhonen KA; Anttila MA; Sillanpää SM; Hämäläinen KM; Saarikoski SV; Juhola M; Kosma VM Eur J Cancer; 2007 May; 43(8):1300-7. PubMed ID: 17448653 [TBL] [Abstract][Full Text] [Related]
15. The relationship of molecular markers of p53 function and angiogenesis to prognosis of stage I epithelial ovarian cancer. Goodheart MJ; Ritchie JM; Rose SL; Fruehauf JP; De Young BR; Buller RE Clin Cancer Res; 2005 May; 11(10):3733-42. PubMed ID: 15897570 [TBL] [Abstract][Full Text] [Related]
16. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma. Yildiz E; Ayan S; Goze F; Gokce G; Gultekin EY BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177 [TBL] [Abstract][Full Text] [Related]
17. Increased angiogenesis is associated with poor prognosis of squamous cell carcinoma of the vulva. Näyhä VV; Stenbäck FG Acta Obstet Gynecol Scand; 2007; 86(11):1392-7. PubMed ID: 17943471 [TBL] [Abstract][Full Text] [Related]
18. Expression of cyclooxygenase-2 in advanced stage ovarian serous carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, and survival. Ali-Fehmi R; Morris RT; Bandyopadhyay S; Che M; Schimp V; Malone JM; Munkarah AR Am J Obstet Gynecol; 2005 Mar; 192(3):819-25. PubMed ID: 15746677 [TBL] [Abstract][Full Text] [Related]
19. Co-expression of angiogenic markers and associations with prognosis in advanced epithelial ovarian cancer: a Gynecologic Oncology Group study. Secord AA; Darcy KM; Hutson A; Lee PS; Havrilesky LJ; Grace LA; Berchuck A; Gynecol Oncol; 2007 Jul; 106(1):221-32. PubMed ID: 17481705 [TBL] [Abstract][Full Text] [Related]
20. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer. Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]